Cite

Representative electropherogram of homozygous patient with genotype *4/*4.
Representative electropherogram of homozygous patient with genotype *4/*4.

A) Representative electropherogram of a heterozygous patient without a duplication. B) Representative electropherogram of a heterozygous patient with a duplication.
A) Representative electropherogram of a heterozygous patient without a duplication. B) Representative electropherogram of a heterozygous patient with a duplication.

The calculated percentage of metabolizing classes within the Macedonian, Albanian and Romany population (EM: extensive metabolizers; IM: intermediate metabolizers; PM: poor metabolizers; UM: ultrarapid metabolizers).
The calculated percentage of metabolizing classes within the Macedonian, Albanian and Romany population (EM: extensive metabolizers; IM: intermediate metabolizers; PM: poor metabolizers; UM: ultrarapid metabolizers).

CYP2D6 allele frequency in Macedonians, Albanians and Romanies.

Allele and SNPLocationAmino Acid ChangedbSNP IDFunctional EffectAllele Frequency
MacedoniansAlbaniansRomanies
*1: wild typenormal0.3650.3700.330
*2: 2850(C>T) 4180 (G>C)exon 2 exon 6Arg296Cys Ser486Thrrs16947 rs1135840normal0.2550.2150.255
*3: 2549delAexon 5frameshiftrs35742686none0.0200.0350.015
*4: 1846 (G>A)intron 3 - exon 4 junctionsplicing defectrs3892097none0.1700.2250.150
*5gene deletionnone0.0150.0250.005
*6: 1707delTframeshiftrs5030655none0.0100.0150.005
*9: 2615-2617delAAGLys281delrs5030656decreased0.0000.0050.005
*10: 100 (C>T)exon 1Pro34Serrs1065852decreased0.0150.0050.000
*17: 1023 (C>T)exon 2Thr107Ilers28371706decreased0.0000.0000.000
*29: 1661 (G>C)Arg36Hisrs61736512decreased0.0150.0000.000
*41: 2988 (G>A)Glu242Lysrs28371725decreased0.1100.1050.230
*1xNgene duplicationincreased0.0200.0000.005
*2xNgene duplicationincreased0.0050.0050.000

Genotype frequency of determined CYP2D6 genotypes and corresponding phenotypes.

PredictedGenotypeFrequency in Macedonians (%)Frequency in Albanians (%)Frequency in Romanies (%)
Ultrarapid metabolizer*1xN/*10.010.000.00
*1xN/*20.030.000.01
*2xN/*20.010.010.00
Extensive metabolizer*1/*10.140.150.13
*1/*20.200.130.17
*1/*90.000.000.01
*1/*100.020.000.00
*1/*290.010.000.00
*2/*290.010.000.00
*1/*410.050.080.12
*2/*20.060.050.07
*2/*30.010.020.00
*2/*410.050.030.17
Intermediate metabolizer*1/*30.010.030.01
*1/*40.130.170.07
*1/*50.020.020.01
*1/*60.000.020.01
*2/*40.090.120.02
*2/*50.010.000.00
*2/*60.000.010.00
*41/*410.030.020.03
*9/*410.000.010.00
*4/*410.040.040.09
*4/*290.010.000.00
*6/*100.010.000.00
*6/*410.010.000.00
*3/*410.000.010.02
*4/*100.000.010.00
Poor metabolizer*3/*30.010.000.00
*3/*40.000.010.00
*4/*50.000.030.00
*4/*40.030.030.06

Comparison of CYP2D6allele frequencies in different populations.

PopulationRefsFunctionalNon FunctionalReducedDuplications
*1*2*3*4*5*6*9*10*17*29*41*1xN*2xN
French1528.0032.000.0016.004.000.004.002.000.000.0010.002.000.00
Sardinian1528.6035.701.8021.401.800.000.005.400.000.003.600.001.80
Russian1532.0034.000.0020.000.000.000.000.000.000.008.000.004.00
German3236.4032.402.0020.702.000.901.801.500.501.30
Croatian2976.502.7514.001.001.504.00
Greek302.3017.846.01
Czech311.1222.873.140.023.14
Bedouin1535.7020.400.005.104.102.000.000.003.100.0022.401.002.00
Macedonian2724.9010.800.8018.709.100.001.602.708.605.90

The article does not clearly explain on which alleles the duplications occur.

Macedonian

This study.

36.5025.502.0017.001.501.000.001.500.001.5011.002.000.50
Albanian

This study.

37.0021.503.5022.502.501.500.500.500.000.0010.500.000.50
Romany

This study.

33.0025.401.5015.000.500.500.500.000.000.0023.000.500.00

CYP2D64 major phenotype classes and two subclasses [4,7]The phenotypes were derived from the Human Cytochrome P450 (CYP) Allele Nomenclature Committee website [4] and the PharmGKB website for the related Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2D6 [7]..

Predicted Drug Metabolizing Phenotype

UM: ultrarapid metabolizer; EM: extensive metabolizer; IM: intermediate metabolizer; PM: poor metabolizer.

Combination of Alleles
UMA combination of one normal activity allele with one increased activity allele
EMTwo normal activity alleles; a combination of one increased activity allele with one decreased activity allele
IM to EMA combination of one normal activity allele with one decreased activity allele; a combination of one increased activity allele with one null activity allele
IMOne normal activity allele with one null activity allele; two decreased activity alleles
PM to IMA combination of one decreased activity allele with one null activity allele
PMOnly null activity alleles detected
eISSN:
1311-0160
Language:
English
Publication timeframe:
2 times per year
Journal Subjects:
Medicine, Basic Medical Science, other